34 GENES FOUND

? »

Page of 1

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ABCA1ATP-binding cassette, sub-family A (ABC1), member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCC1ATP-binding cassette, sub-family C (CFTR/MRP), member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ANO1Anoctamin 1, calcium activated chloride channelFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Transporters
Expressed in all
ATP1A1ATPase, Na+/K+ transporting, alpha 1 polypeptideCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
ATP6V1B2ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2FDA approved drug targets
Transporters
Expressed in all
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Transporters
Tissue enriched
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
CHRNA7Cholinergic receptor, nicotinic, alpha 7 (neuronal)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
GLRA2Glycine receptor, alpha 2FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
RYR1Ryanodine receptor 1 (skeletal)Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A1Solute carrier family 12 (sodium/potassium/chloride transporter), member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A3Solute carrier family 12 (sodium/chloride transporter), member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC22A8Solute carrier family 22 (organic anion transporter), member 8FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC5A2Solute carrier family 5 (sodium/glucose cotransporter), member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC6A1Solute carrier family 6 (neurotransmitter transporter), member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC8A1Solute carrier family 8 (sodium/calcium exchanger), member 1FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
SNAP25Synaptosomal-associated protein, 25kDaFDA approved drug targets
Transporters
Tissue enriched
TSPOTranslocator protein (18kDa)Cancer-related genes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Transporters
Expressed in all
UGCGUDP-glucose ceramide glucosyltransferaseEnzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all

Page of 1